These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28762602)

  • 1. Hematopoietic stem cell transplantation in pediatric patients with acute myeloid leukemia without favorable cytogenetics.
    Suh JK; Lee SW; Koh KN; Im HJ; Choi ES; Jang S; Park CJ; Seo JJ
    Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28762602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia.
    Koh KN; Park M; Kim BE; Bae KW; Im HJ; Seo JJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):281-8. PubMed ID: 21464766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
    Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate- or high-risk cytogenetics.
    Park EG; Yi ES; Choi YB; Sung KW; Koo HH; Yoo KH
    Pediatr Transplant; 2019 Jun; 23(4):e13397. PubMed ID: 30955250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation.
    Kondo T; Yasumoto A; Arita K; Sugita J; Shigematsu A; Okada K; Takahata M; Onozawa M; Kahata K; Takeda Y; Obara M; Yamamoto S; Endo T; Nishio M; Sato N; Tanaka J; Hashino S; Koike T; Asaka M; Imamura M
    Int J Hematol; 2010 Mar; 91(2):310-21. PubMed ID: 20087795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.
    Locatelli F; Masetti R; Rondelli R; Zecca M; Fagioli F; Rovelli A; Messina C; Lanino E; Bertaina A; Favre C; Giorgiani G; Ripaldi M; Ziino O; Palumbo G; Pillon M; Pession A; Rutella S; Prete A
    Bone Marrow Transplant; 2015 Feb; 50(2):181-8. PubMed ID: 25387094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cytogenetic model predicts relapse risk and survival in patients with acute myeloid leukemia undergoing hematopoietic stem cell transplantation in morphologic complete remission.
    Rashidi A; Cashen AF
    Leuk Res; 2015 Jan; 39(1):77-81. PubMed ID: 25481050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia.
    Tomizawa D; Tanaka S; Kondo T; Hashii Y; Arai Y; Kudo K; Taga T; Fukuda T; Goto H; Inagaki J; Koh K; Ohashi K; Ozawa Y; Inoue M; Kato K; Tanaka J; Atsuta Y; Adachi S; Ishida H
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1515-1522. PubMed ID: 28501543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience.
    Alloin AL; Leverger G; Dalle JH; Galambrun C; Bertrand Y; Baruchel A; Auvrignon A; Gandemer V; Ragu C; Loundou A; Bilhou-Nabera C; Lafage-Pochitaloff M; Dastugue N; Nelken B; Jubert C; Rialland F; Plat G; Pochon C; Vannier JP; Rohrlich PS; Kanold J; Lutz P; Sirvent A; Oudin C; Cuccuini W; Michel G
    Bone Marrow Transplant; 2017 Apr; 52(4):516-521. PubMed ID: 27941778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review.
    Mateos MK; O'Brien TA; Oswald C; Gabriel M; Ziegler DS; Cohn RJ; Russell SJ; Barbaric D; Marshall GM; Trahair TN
    Pediatr Blood Cancer; 2013 Sep; 60(9):1520-7. PubMed ID: 23733511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
    Novitzky N; Thomas V; du Toit C; McDonald A
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Malard F; Labopin M; Stuhler G; Bittenbring J; Ganser A; Tischer J; Michallet M; Kröger N; Schmid C; Huynh A; Hallek M; Savani BN; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):278-284. PubMed ID: 27816650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
    Grosicki S; Holowiecki J; Kuliczkowski K; Skotnicki A; Hellmann A; Kyrcz-Krzemien S; Dmoszynska A; Sułek K; Kloczko J; Jedrzejczak WW; Warzocha K; Zdziarska B; Wierzbowska A; Pluta A; Komarnicki M; Giebel S
    Am J Hematol; 2015 Oct; 90(10):904-9. PubMed ID: 26149802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
    Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
    Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemia.
    Schechter T; Gassas A; Chen H; Pollard J; Meshinchi S; Zaidman I; Hitzler J; Abdelhaleem M; Ho R; Domm J; Woolfrey A; Frangoul H
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):172-5. PubMed ID: 25139215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.